What we write

What we write

Our resources at your finger tips

The peer review process is a quintessential part of scientific advancement and something Branding Science is passionate about. Our research, and that of our consulting arm, Brand Sight International, has led us to explore numerous disease areas as well as endeavour to solve an extensive number of key business issues.

The links below offers a peek inside the Branding Science Laboratory and only touch on the experience our team has accumulated. Feel free to contact us for more information on any of these articles or methodologies – the lab door is always open!

  • #hashtagpharma: Pharma and the need for social media Social media is no longer just an option for pharmaceutical companies; it is now a necessity in order to fully engage with customers. Following the stories of Johnson & Johnson’s foray into social media exposure and other companies’ attempts at entering the online world, we explore how pharma should balance its inherent - and necessary - conservatism with its original sense of entrepreneurship to fully take advantage of the social media sphere.
  • A Pain in the ….. Shoulder? In the wake of Olympic and Paralympic fever in 2012, Branding Science looks behinds the scenes at the impact competing at such a high level takes on athletes. With injury leading to long term musculoskeletal damage, there is a clear need for preventative measures and effective treatment. We look at how this growing market and the factors affecting it reaching $57 billion by 2014.
  • Access Denied? The implementation of the UK's Health and Social Care Act 2012 has created a number of strategic challenges for new products when it comes to market access in the UK. It also raises questions around what the Commissioners are looking for. To meet these challenges Branding Science looks at how working at a global and local level can yield the required insight to shape your market access message and deliver brand value.
  • Communicating diabetes to the online masses – how can pharma take advantage? With an estimated one in seven adults at risk of developing it, diabetes offers a wealth of opportunities for the pharmaceutical industry. Branding Science considers the increasing trend of reaching out to patients online via mobile apps and websites like YouTube, as well as pharmaceutical-run websites. By analyzing the future of digital diabetes resources, we explore how pharma companies are well placed to take advantage to raise their profile in the world of diabetes and to become a trusted partner among physicians and patients alike.
  • Definitions and Importance of Patient Adherence to the Pharmaceutical Industry Taken from an EphMRA webinar featuring Peter Cunningham our CEO, this article looks at the subject of adherence and particularly non-adherence. With pharma companies losing 5% of their client-base to non-adherence every month - this is a clearly prevalent topic. In conjunction with Julie Buis from Aequus Research, Peter outlines the key elements of adherence and offers solutions as to how the pharmaceutical industry can create a “new normal” in this area.
  • How advances in genetic sequencing give us the power to take control of our health In 1967, two researchers from UCL discovered the links between being overweight, smoking, pressure at work, and the chances of developing coronary heart disease. Branding Science further investigates the correlation between environment and health, concentrating on how the power of genetic sequencing technology is ushering us into new era with an emphasis on preventative medicine, allowing diseases to be treated earlier than ever before.
  • How to Discover the Untold? How do you investigate covert, underlying attitudes, both conscious and unconscious? Understanding the attitudes that drive behaviour is critical for marketers to gain a clear view of consumer conduct. This article looks at new research methodologies that can provide new layers of information for pharmaceutical brand teams and reinforce the strategic directions their marketing must follow.
  • Market Access Empowerment Constantly having the right tools and information to meet the challenges of a competitive, evolving market is a situation faced by all pharmaceutical companies. Branding Science discusses how integrating market access early in a product’s development can generate tangible solutions. This article highlights how sound customer understanding can drive a company’s marketing strategy to allow it to stay innovative in the eyes of its clients and competitors.
  • Mining Instinct Studying physician prescription tendencies using traditional qualitative and quantitative methods is something Branding Science specialises in. However, as part of a constant strive to improve current methodologies, we look look at the Rapid Physician Decision task – a computer based task which incorporates into qualitative interviews. This article discusses how combining qualitative and quantitative methods can increase the amount of insight gathered from market research projects.
  • Mobile health and today’s pharmaceutical industry Few pieces of technology have seamlessly integrated themselves into everyday life as much as the smartphone. Their use has transcended pure communication tools, and they are now becoming the centre piece of the latest digital trend – wearable tech. This has begun to place the smartphone at the centre of a healthcare revolution and Branding Science looks at how this will affect both patients and physicians and how pharmaceutical companies can connect with the mobile population.
  • Patient Power in Oncology Oncology is one of the most crowded market areas for pharmaceutical companies and is becoming increasingly patient driven. Now, as targeted therapeutics have become an established part of treatment pathways, the need for precise, relevant and targeted market research is paramount. With this in mind, Branding Science assesses the changes in market dynamics and the need to alter current marketing techniques in order to capture both the hearts and minds of today’s oncology patients.
  • Personalised Medicine The personalisation of medicine is not a future trend, but a critical current one, and the opportunity for pharmaceutical companies to take advantage in order to form relationships with patients and physicians alike is emerging in a striking fashion. Branding Science investigates how this potential to engage both sets of stakeholders will allow pharma to gain a stronghold in the growing personalized health world, while also enabling people to help themselves.
  • The Science of Logo Design Semiotics, etymology and pharmaceutical logos…? Branding science ventures into the world of Charles Saunders Price to investigate how an understanding of logo design and communication relates to pharmaceutical brands. Using examples from everyday imagery, we look at how three key types of iconography emerge from a survey of MIMS and GP magazines and how a greater understanding of logo design can have practical implications for market research.